Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial
(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and month 12 who did or did not receive alternative anemia therapy or permanently discontinued study therapy before month 12. BL, baseline; FCM, ferric carboxymaltose. (ZIP 456Â kb)
Macdougall, I. C., Bock, A. H., Carrera, F., Eckardt, K-U., Gaillard, C., Van Wyck, D., Meier, Y., Larroque, S., Roger, S. D. & FIND-CKD Study Investigators, 17-Jan-2017, In: Bmc nephrology.18, 24, 18 p.
Research output: Contribution to journal › Article › Academic › peer-review
Open Access
File
8Citations
(Scopus)
702Downloads
(Pure)
Cite this
DataSetCite
Macdougall, I. C. (Contributor), Bock, A. H. (Contributor), Carrera, F. (Contributor), Eckardt, K. (Contributor), Gaillard, C. (Contributor), Van Wyck, D. (Contributor), Meier, Y. (Contributor), Larroque, S. (Contributor), Roger, S. D. (Contributor) (17-Jan-2017). Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial. University of Groningen. 10.6084/m9.figshare.c.3667405_d5.v1